INTRODUCTION: Patients with COPD have decreased exercise capacity and low oxygen consumption (Vo(2)) during formal cardiopulmonary exercise testing, and lower scores on health-related quality of life questionnaires. When isolated, these three variables show different correlations with COPD mortality. The multidimensional BODE (body mass index[BMI], airflow obstruction, dyspnea, and exercise capacity in COPD) index, which comprises four variables including the 6-min walk test (6MWT), predicts survival in COPD. OBJECTIVES: To evaluate the degree of association between the values of the BODE index using the 6MWT with the BODE index using maximal Vo(2) (Vo(2)max) obtained in a maximal incremental test. MATERIALS AND METHODS: Fifty patients with mild-to-severe COPD (average age, 63.5 +/- 9.9 years; FEV(1), 65.3 +/- 23.6% of predicted) [+/- SD] had BMI, spirometric function (FVC and FEV(1)), and dyspnea status (Medical Research Council) evaluated. Two BODE index scores were then completed: one with the 6MWT, and one with the Vo(2)max obtained during maximal incremental testing on a treadmill. RESULTS: Correlation between BODE index and Vo(2) in milliliters per minute per kilogram (r = - 0.41) was weak; the correlation was moderate (r = - 0.64) when Vo(2) percentage of predicted was used. The BODE index modified by replacing the 6MWT with Vo(2) showed excellent correlations with Vo(2) in milliliters per minute per kilogram (r = 0.92) and Vo(2) percentage of predicted (r = 0.95). CONCLUSION: The excellent correlation between the conventional BODE index and the modified BODE index with Vo(2) replacing the 6MWT enables us to reach the conclusion that the original BODE index is very effective in the evaluation of COPD patients.
INTRODUCTION:Patients with COPD have decreased exercise capacity and low oxygen consumption (Vo(2)) during formal cardiopulmonary exercise testing, and lower scores on health-related quality of life questionnaires. When isolated, these three variables show different correlations with COPD mortality. The multidimensional BODE (body mass index[BMI], airflow obstruction, dyspnea, and exercise capacity in COPD) index, which comprises four variables including the 6-min walk test (6MWT), predicts survival in COPD. OBJECTIVES: To evaluate the degree of association between the values of the BODE index using the 6MWT with the BODE index using maximal Vo(2) (Vo(2)max) obtained in a maximal incremental test. MATERIALS AND METHODS: Fifty patients with mild-to-severe COPD (average age, 63.5 +/- 9.9 years; FEV(1), 65.3 +/- 23.6% of predicted) [+/- SD] had BMI, spirometric function (FVC and FEV(1)), and dyspnea status (Medical Research Council) evaluated. Two BODE index scores were then completed: one with the 6MWT, and one with the Vo(2)max obtained during maximal incremental testing on a treadmill. RESULTS: Correlation between BODE index and Vo(2) in milliliters per minute per kilogram (r = - 0.41) was weak; the correlation was moderate (r = - 0.64) when Vo(2) percentage of predicted was used. The BODE index modified by replacing the 6MWT with Vo(2) showed excellent correlations with Vo(2) in milliliters per minute per kilogram (r = 0.92) and Vo(2) percentage of predicted (r = 0.95). CONCLUSION: The excellent correlation between the conventional BODE index and the modified BODE index with Vo(2) replacing the 6MWT enables us to reach the conclusion that the original BODE index is very effective in the evaluation of COPDpatients.
Authors: José Luis Lopez-Campos; Pilar Cejudo; Eduardo Marquez; Francisco Ortega; Esther Quintana; Carmen Carmona; Emilia Barrot Journal: Int J Chron Obstruct Pulmon Dis Date: 2010-05-06
Authors: Donald A Mahler; Joseph Ward; Laurie A Waterman; Corliss McCusker; Richard ZuWallack; John C Baird Journal: Chest Date: 2009-08-20 Impact factor: 9.410
Authors: Wouter D van Dijk; Lisette van den Bemt; Saskia van den Haak-Rongen; Erik Bischoff; Chris van Weel; Johannes C C M in 't Veen; Tjard R J Schermer Journal: Respir Res Date: 2011-11-14
Authors: Beniamino Guerra; Sarah R Haile; Bernd Lamprecht; Ana S Ramírez; Pablo Martinez-Camblor; Bernhard Kaiser; Inmaculada Alfageme; Pere Almagro; Ciro Casanova; Cristóbal Esteban-González; Juan J Soler-Cataluña; Juan P de-Torres; Marc Miravitlles; Bartolome R Celli; Jose M Marin; Gerben Ter Riet; Patricia Sobradillo; Peter Lange; Judith Garcia-Aymerich; Josep M Antó; Alice M Turner; Meilan K Han; Arnulf Langhammer; Linda Leivseth; Per Bakke; Ane Johannessen; Toru Oga; Borja Cosio; Julio Ancochea-Bermúdez; Andres Echazarreta; Nicolas Roche; Pierre-Régis Burgel; Don D Sin; Joan B Soriano; Milo A Puhan Journal: BMC Med Date: 2018-03-02 Impact factor: 8.775
Authors: Nveed Chaudhary; Karsta Luettich; Michael J Peck; Elena Pierri; Loyse Felber-Medlin; Gregory Vuillaume; Patrice Leroy; Julia Hoeng; Manuel C Peitsch Journal: F1000Res Date: 2017-06-13
Authors: Lara Siebeling; Jammbe Z Musoro; Ronald B Geskus; Marco Zoller; Patrick Muggensturm; Anja Frei; Milo A Puhan; Gerben ter Riet Journal: NPJ Prim Care Respir Med Date: 2014-08-28 Impact factor: 2.871
Authors: Jilles M Fermont; Divya Mohan; Marie Fisk; Charlotte E Bolton; William Macnee; John R Cockcroft; Carmel McEniery; Jonathan Fuld; Joseph Cheriyan; Ruth Tal-Singer; Hana Müllerova; Angela M Wood; Ian B Wilkinson; Michael I Polkey Journal: Age Ageing Date: 2021-05-05 Impact factor: 10.668